Evidence map›Paper›PMID 33131499›Full record

ArticleOrphanet journal of rare diseases2020

Maple syrup urine disease in Brazilian patients: variants and clinical phenotype heterogeneity.

Ana Vitoria Barban Margutti, Wilson Araújo Silva, Daniel Fantozzi Garcia, Greice Andreotti de Molfetta, Adriana Aparecida Marques, Tatiana Amorim, Vânia Mesquita Gadelha Prazeres, Raquel Tavares Boy da Silva, Irene Kazue Miura, João Seda Neto and 8 more

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Genotypic and phenotypic spectrum of maple syrup urine disease in Zhejiang of China.QJM : monthly journal of the Association of Physicians · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Metabolomics of neurological disorders in India.Analytical science advances · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Ana Vitoria Barban MarguttiDepartment of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Bandeirantes Av., 3900 - HC Criança - off D506, Ribeirão Prêto, SP, 14049-900, Brazil.ORCID 0000-0003-2163-4523
Wilson Araújo SilvaDepartment of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID 0000-0001-9364-2886
Daniel Fantozzi GarciaDepartment of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID 0000-0002-1243-424X
Greice Andreotti de MolfettaDepartment of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.ORCID 0000-0003-0946-5704
Adriana Aparecida MarquesNational Institute of Science and Technology in Stem Cell, and Cell Therapy, Regional Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.ORCID 0000-0002-7549-8574
Tatiana AmorimAssociação de Pais e Amigos dos Excepcionais of Salvador, Salvador, BA, Brazil.ORCID 0000-0002-0371-9104
Vânia Mesquita Gadelha PrazeresFederal University of Amazonas, Manaus, AM, Brazil.ORCID 0000-0001-9531-1706
Raquel Tavares Boy da SilvaDepartment of Pediatrics, Medical Sciences School, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil.ORCID 0000-0001-6432-4870
Irene Kazue MiuraSírio-Libanês Hospital, São Paulo, SP, Brazil.ORCID 0000-0001-9400-6697
João Seda NetoSírio-Libanês Hospital, São Paulo, SP, Brazil.ORCID 0000-0003-2267-5386
Emerson de Santana SantosDepartment of Medicine, Federal University of Sergipe, São Cristóvão, SE, Brazil.ORCID 0000-0002-9175-2210
Mara Lúcia Schmitz Ferreira SantosPequeno Príncipe Hospital, Curitiba, PR, Brazil.ORCID 0000-0002-5253-988X
Charles Marques LourençoMedical School, Estácio University Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil.ORCID 0000-0002-2296-6098
Tássia TononPosgraduate Programme in Medicine - Medical Sciences, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil.ORCID 0000-0001-8504-7526
Fernanda Sperb-LudwigDepartment of Genetics, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil.ORCID 0000-0002-2460-7064
Carolina Fischinger Moura de SouzaMedical Genetics Service, Clinics Hospital of Porto Alegre, Department of Genetics, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil.ORCID 0000-0002-7280-6260
Ida Vanessa Döederlein SchwartzMedical Genetics Service, Clinics Hospital of Porto Alegre, Department of Genetics, Federal University of Rio Grande Do Sul, Porto Alegre, RS, Brazil.ORCID 0000-0002-7933-6687
José Simon CameloDepartment of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Bandeirantes Av., 3900 - HC Criança - off D506, Ribeirão Prêto, SP, 14049-900, Brazil. jscamelo@fmrp.usp.br.ORCID 0000-0002-4555-7633
Universidade de São Paulo · BRHospital Sírio-Libanês · BRUniversidade Federal do Rio Grande do Sul · BREstácio (Brazil) · BRUniversidade de Ribeirão Preto · BRUniversidade do Estado da Bahia · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Federal de Sergipe · BRUniversidade Federal do Amazonas · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaple syrup urine disease (MSUD) is an autosomal recessive inherited metabolic disease caused by deficient activity of the branched-chain α-keto acid dehydrogenase (BCKD) enzymatic complex. BCKD is a mitochondrial complex encoded by BCKDHA, BCKDHB, DBT, and DLD genes. MSUD is predominantly caused by Variants in BCKDHA, BCKDHB, and DBT genes encoding the E1α, E1β, and E2 subunits of BCKD complex, respectively. The aim of this study was to characterize the genetic basis of MSUD by identifying the point variants in BCKDHA, BCKDHB, and DBT genes in a cohort of Brazilian MSUD patients and to describe their phenotypic heterogeneity. It is a descriptive cross-sectional study with 21 MSUD patients involving molecular genotyping by Sanger sequencing.

resultsEight new variants predicted as pathogenic were found between 30 variants (damaging and non-damaging) identified in the 21 patients analyzed: one in the BCKDHA gene (p.Tyr120Ter); five in the BCKDHB gene (p.Gly131Val, p.Glu146Glnfs * 13, p.Phe149Cysfs * 9, p.Cys207Phe, and p.Lys211Asn); and two in the DBT gene (p.Glu148Ter and p.Glu417Val). Seventeen pathogenic variants were previously described and five variants showed no pathogenicity according to in silico analysis.

conclusionGiven that most of the patients received late diagnoses, the study results do not allow us to state that the molecular features of MSUD variant phenotypes are predictive of clinical severity.

Indexed as

Maple Syrup Urine Disease3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)BrazilCross-Sectional StudiesHumansPhenotype3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)Branched-chain amino acidsInborn errors of metabolismIsoleucineLeucineMaple syrup urine diseaseValine

Identifiers

PMID33131499
PMCPMC7603684
OpenAlexW3096981410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.